Overview Performance Portfolio Dividends Charges Gearing Research Announcements Management Documents Invest

Data as at: 08/10/2024

Set up your portfolio View your portfolio
Objective
To achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies.
AIC sector
Biotechnology & Healthcare
Management group
RTW Investments
Company website
RTW Biotech Opportunities website
Launch date
29/10/2019
Financial year end
December
Next AGM date
09/10/2024
Domicile
Guernsey
Fund manager
Naveen Yalamanchi, Roderick Wong, Stephanie Sirota, Sabera Loughran
Dividend frequency
Data Not Available
Wind-up provisions
The Company has an unlimited life.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
520.36 674.78 1.55 2.01 -23.88 0 0.00 N/A 1.87 (31/12/2023)
Scroll

Note

RTW Biotech Opportunities has an additional market quote in sterling.

Dividends

Dividends declared in last 12 months

There have been no dividends in the last 12 months.

Performance (%)

Return type 1 year 3 years 5 years 10 years
RTW Biotech Opportunities Share price total return 27.1 -19.7 N/A N/A
Biotechnology & Healthcare AIC sector Share price total return 11.9 -9.1 11.9 108.9
Scroll

Share structure

Number of shares
335,713,649
Number of treasury shares
10,253,791

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 761,386 3,362,025 112,112,911 0
Average N/A 187,428 444,387 0
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total 1.18 5.11 151.83 0
Average N/A 0.29 0.60 0
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GG00BKTRRM22 RTW USD London Stock Exchange - MAIN
Chi-x Europe Limited
London Stock Exchange
Scroll

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.